0001415889-23-002168.txt : 20230208 0001415889-23-002168.hdr.sgml : 20230208 20230208175804 ACCESSION NUMBER: 0001415889-23-002168 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230207 FILED AS OF DATE: 20230208 DATE AS OF CHANGE: 20230208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gelder Mark S. MD CENTRAL INDEX KEY: 0001564390 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36020 FILM NUMBER: 23600310 MAIL ADDRESS: STREET 1: C/O A.P. PHARMA, INC. STREET 2: 123 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Onconova Therapeutics, Inc. CENTRAL INDEX KEY: 0001130598 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 BUSINESS PHONE: 267-759-3681 MAIL ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC. DATE OF NAME CHANGE: 20090526 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC DATE OF NAME CHANGE: 20001226 4 1 form4-02082023_100255.xml X0306 4 2023-02-07 0001130598 Onconova Therapeutics, Inc. ONTX 0001564390 Gelder Mark S. MD C/O ONCONOVA THERAPEUTICS, INC 12 PENNS TRAIL NEWTOWN PA 18940 false true false false CHIEF MEDICAL OFFICER Common Stock 2023-02-07 4 M 0 5833 A 11729 D Common Stock 2023-02-07 4 F 0 1242 1.36 D 10487 D Restricted Stock Units 2023-02-07 4 M 0 5833 0 D Common Stock 5833 11667 D Restricted stock units convert into common stock on a one-for-one basis. On February 7, 2022 the reporting person was granted 17,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary. /s/ Mark Guerin, Attorney-in-Fact 2023-02-08